NASDAQ:SNSE
Sensei Biotherapeutics, Inc.
- Stock
Last Close
1.04
26/04 20:00
Market Cap
20.00M
Beta: −0.20
Volume Today
6.14K
Avg: 84.31K
PE Ratio
−0.55
PFCF: −0.57
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
account payables | 1.11M - | 3.45M 211.46% | 3.88M 12.49% | 2.46M 36.73% | 1.69M - | ||
accumulated other comprehensive income loss | -314K - | -333K - | -1.00M 201.50% | -209K 79.18% | |||
cash and cash equivalents | 653K - | 251K 61.56% | 16.60M 6,511.95% | 7.16M 56.86% | 17.80M 148.57% | 13.01M 26.88% | |
cash and short term investments | 653K - | 251K 61.56% | 16.60M 6,511.95% | 147.62M 789.50% | 17.80M 87.95% | 65.76M 269.53% | |
common stock | 3K - | 3K 0% | 3K 0% | ||||
deferred revenue | 652K - | 2.08M 219.48% | |||||
deferred revenue non current | |||||||
deferrred tax liabilities non current | |||||||
goodwill | |||||||
goodwill and intangible assets | |||||||
intangible assets | |||||||
inventory | |||||||
long term debt | 4.05M - | 567K - | 1.67M 195.24% | 5.90M 252.57% | 3.77M 36.14% | ||
long term investments | |||||||
net debt | 4.09M - | 15.80M 286.12% | -16.03M 201.42% | -4.80M 70.02% | -9.76M 103.16% | -6.80M 30.31% | |
net receivables | |||||||
other assets | -1K - | 1 100.10% | |||||
other current assets | 123K - | 3.48M - | 374K 89.25% | 344K 8.02% | 1.49M 334.01% | ||
other current liabilities | 207K - | 125K 39.61% | 948K 658.40% | 1.75M 84.92% | 6.93M 295.61% | 1.51M 78.23% | |
other liabilities | 1 - | ||||||
other non current assets | 447K - | 447K 0% | 86K 80.76% | 39K 54.65% | 63K 61.54% | 86.00K 36.51% | |
other non current liabilities | 48.62M - | 48.16M 0.93% | 72.47M 50.47% | 149K 99.79% | 67.00K - | ||
othertotal stockholders equity | -25.14M - | -23.89M 4.95% | -16.37M 31.50% | 142.82M 972.63% | 302.20M 111.59% | 297.00M 1.72% | |
preferred stock | 47.55M - | 47.55M 0% | 72.34M 52.14% | 153.22M 111.82% | |||
property plant equipment net | 123K - | 268K 117.89% | 1.27M 372.39% | 4.64M 266.82% | 9.72M 109.39% | 7.04M 27.62% | |
retained earnings | -75.57M - | -92.31M 22.15% | -112.41M 21.77% | -149.21M 32.73% | -197.79M 32.56% | -231.90M 17.24% | |
short term debt | 696K - | 16.05M 2,206.75% | 680K - | 2.13M 213.38% | 2.44M 14.45% | ||
short term investments | 140.46M - | 89.32M 36.41% | 52.75M 40.95% | ||||
tax assets | |||||||
tax payables | |||||||
total assets | 1.85M - | 1.22M 34.22% | 21.43M 1,660.72% | 153.22M 615.07% | 118.38M 22.74% | 74.37M 37.17% | |
total current assets | 1.28M - | 502K 60.78% | 20.08M 3,899.20% | 148.54M 639.90% | 108.59M 26.90% | 67.25M 38.07% | |
total current liabilities | 2.66M - | 21.71M 715.40% | 4.83M 77.76% | 4.89M 1.22% | 9.07M 85.44% | 5.64M 37.76% | |
total debt | 4.75M - | 16.05M 238.28% | 567K 96.47% | 2.35M 315.17% | 8.03M 241.25% | 6.21M 22.72% | |
total investments | 140.46M - | 89.32M 36.41% | 52.75M 40.95% | ||||
total liabilities | 55.33M - | 69.88M 26.29% | 77.87M 11.44% | 6.71M 91.38% | 14.97M 123.00% | 9.48M 36.67% | |
total liabilities and stockholders equity | 1.85M - | 1.22M 34.22% | 21.43M 1,660.72% | 153.22M 615.07% | 118.38M 22.74% | 74.37M 37.17% | |
total non current assets | 570K - | 715K 25.44% | 1.35M 89.09% | 4.68M 246.38% | 9.79M 108.99% | 7.12M 27.21% | |
total non current liabilities | 52.67M - | 48.16M 8.55% | 73.04M 51.65% | 1.82M 97.50% | 5.90M 223.75% | 3.84M 35.01% | |
total stockholders equity | -53.48M - | -68.66M 28.39% | -56.44M 17.80% | 146.51M 359.58% | 103.41M 29.42% | 64.89M 37.24% |
All numbers in USD (except ratios and percentages)